By SmokerBar Editorial Team

If you’ve seen VELO nicotine pouches online or in stores, you might have wondered: Is this just another form of vaping? It’s a fair question. Both products offer smoke‑free alternatives to cigarettes, both deliver nicotine without combustion, and both have gained massive popularity in recent years.

But the answer is clear: VELO is not a form of vaping. In fact, they couldn’t be more different. VELO delivers nicotine through your gums — no heat, no smoke, no vapour. Vaping relies on inhaling aerosol produced by heating e‑liquid. One involves your lungs; the other doesn’t.

As VELO’s official product description states: “They deliver nicotine through the gums — no heat, no smoke*, no vapour”.

In this 2026 guide, we will break down exactly how VELO differs from vaping — from the science of absorption to health considerations, convenience, and market trends — so you can understand exactly what VELO is and whether it might be right for you.

What Is VELO? A Quick Refresher

VELO nicotine pouches are small, discreet, tobacco‑free pouches designed to be placed between your upper lip and gum. They contain pharmaceutical‑grade nicotine, plant‑based fibres, water, food‑grade flavourings, and sweeteners — but no tobacco leaf.

You simply pop a pouch under your lip, leave it there for about 30 minutes, and nicotine is absorbed directly through the oral mucosa into your bloodstream. There is no smoke, no vapour, no spitting, no lingering odour, and no device to charge or maintain.

According to VapeMate’s 2026 review, VELO pouches are “a tobacco free, smoke free and vapour-free way to enjoy nicotine, offering a convenient and discreet alternative to smoking or vaping”. Because there’s no combustion or vapour, “VELO pouches won’t trigger smoke alarms, making them a truly discreet nicotine option”.

The brand is produced by British American Tobacco (BAT) to strict quality standards and has become the second‑largest nicotine pouch brand in the US, behind only ZYN.

What Is Vaping? A Quick Comparison

Vaping — also known as using an e‑cigarette — involves inhaling aerosol produced by heating an e‑liquid. The e‑liquid typically contains nicotine, propylene glycol, vegetable glycerine, and flavourings. The device heats the liquid to create an aerosol (often called “vapour”), which is then inhaled into the lungs.

Unlike cigarettes, vaping involves no combustion — but it still involves inhalation. The aerosol deposits nicotine and other chemicals directly into the respiratory system. This means the lungs are directly exposed, even if the risk profile is generally considered lower than smoking.

Vape kits require ongoing maintenance: charging batteries, refilling or replacing pods or coils, and cleaning the device. Disposable vapes, once popular, are now banned in the UK as of 2025, pushing many adult vapers toward alternatives like nicotine pouches.

The Key Differences at a Glance

The Science: How VELO Delivers Nicotine Without Vapour

The fundamental difference lies in the absorption pathway.

Vaping relies on pulmonary absorption — inhaling an aerosol deep into the lungs, where the large surface area and rich blood supply allow rapid nicotine uptake. This mimics the fast delivery of cigarettes, producing a quick “hit”.

VELO relies on buccal absorption — placing the pouch between your upper lip and gum, where nicotine passes directly through the thin, vascularised oral mucosa into the bloodstream. No inhalation. No lungs. No aerosol.

A 2025 clinical study published in the Journal of Clinical Pharmacology examined how VELO nicotine pouches deliver nicotine to the body. The key findings:

• Nicotine pouches delivered nicotine rapidly and efficiently. Maximum blood levels of nicotine (Cmax) were reached quickly, approximating concentrations similar to those obtained from cigarettes, within the first 10 minutes of use.

• Only 1.8% of the nicotine content of a 20mg pouch was detected in saliva, meaning nearly all nicotine absorption occurs through the lining of the mouth — not through swallowing or inhalation.

• Participants generally rated the pouches as acceptable in terms of product liking and intention to use again — an essential factor for successful switching.

Chris Junker, Group Head of Life Sciences at BAT, explained: “Our study findings and wider research show that oral nicotine pouches can deliver nicotine efficiently and rapidly, similar to the effects of cigarette smoking but with reduced exposure to the toxicants associated with use of cigarettes”.

A 2026 pharmacokinetic study further confirmed that nicotine delivery to the consumer increases with duration of use, and that “smokers who switch completely to an NP can obtain their accustomed amount of nicotine during normal product use”.

Because VELO involves no heating, there is no aerosol formation, no inhalation, and no exposure of lung tissue to any foreign substance. This is a fundamental distinction from vaping, which — even without combustion — still deposits aerosolised chemicals directly into the respiratory tract.

Health Considerations: VELO vs. Vaping

Both VELO and vaping are generally considered less harmful than continued cigarette smoking. But the risk profiles differ significantly.

No Lung Exposure

The most important advantage of VELO over vaping is the complete absence of lung exposure. Vaping, even with high‑quality devices and e‑liquids, involves inhaling an aerosol. While the long‑term respiratory effects of vaping are still being studied, known risks include lung inflammation, respiratory irritation, and EVALI (E‑cigarette or Vaping Product Use‑Associated Lung Injury).

VELO completely bypasses the lungs. Nothing is inhaled. Nothing reaches the respiratory tract. This places VELO on the lowest end of the toxicant risk continuum.

According to Medscape’s 2026 analysis, “On the risk continuum, nicotine pouches are likely less harmful than cigarettes and vaping for people who already smoke. That’s because they eliminate tobacco leaf and the inhalation of aerosols containing flavorants and aldehydes”.

Lower Abuse Liability

A 2025 study published in Frontiers in Pharmacology evaluated the abuse liability of VELO oral nicotine pouches compared to cigarettes and nicotine replacement therapy (NRT) gum. The findings are significant:

• Mean product liking scores for all VELO ONPs were significantly lower than cigarettes (p < 0.0042), regardless of nicotine level, pouch size, or flavour, but similar to NRT gum.

• Nicotine uptake with VELO ONPs was slower and had lower peak nicotine levels (Cmax) than cigarettes but was comparable or slightly lower than NRT gum.

• VELO ONPs demonstrated an abuse liability profile lower than cigarettes and similar to NRT gum, suggesting a reduced potential for abuse compared to cigarettes.

This means VELO is less reinforcing and potentially less addictive than cigarettes — and, by extension, likely less addictive than many vaping products that deliver nicotine rapidly through lung absorption.

Toxicant Reduction

A 2025 CORESTA study compared 132 analytes across 11 oral nicotine pouches (including nine VELO products), two snus products, and cigarette smoke. The results:

• 70 analytes were not quantified in any nicotine pouch samples tested.

• A higher number of analytes were present in snus (n = 58) than in nicotine pouches (n = 47) on a per‑pouch basis.

• In most tests, the nicotine pouches contained lower levels of analytes (>90%) than snus.

• All nicotine pouches tested did not exceed the GOTHIATEK® standard’s maximum allowable limits established for snus — the same standard considered in the FDA’s MRTP authorisation for General Snus products.

The study concluded: “The results support the hypothesis that ONPs might offer a potentially reduced risk profile alternative to smoking”.

Remaining Risks

Neither VELO nor vaping is risk‑free. Nicotine itself is addictive and carries cardiovascular risks. A December 2025 expert consensus report in the European Heart Journal concluded that nicotine is a direct cardiovascular toxin, regardless of delivery method. VELO eliminates combustion‑related toxins but does not eliminate nicotine’s cardiovascular effects.

Additionally, because VELO pouches sit directly against the gum tissue, prolonged use can cause localised gum irritation, dry mouth, and potential gum recession if placement is not rotated.

Discreetness and Convenience: Where VELO Excels

One of the biggest practical differences between VELO and vaping is discretion.

VELO pouches are completely invisible during use. You can place one under your lip and go about your day — talking, working, socialising, even attending meetings — with no one the wiser. There is no vapour cloud, no odour, no device to handle. This makes VELO usable in situations where vaping is often prohibited: offices, public transport, restaurants, cinemas, and even flights.

Vaping, by contrast, produces visible exhaled vapour. Even the most discreet vape devices leave a visible cloud, and the vapour carries a noticeable scent. Many public places restrict vaping alongside smoking, limiting where and when you can use it.

VapeMate’s 2026 comparison notes that nicotine pouches “can be used more discreetly and are less noticeable than vapes” and “can be used freely in public areas and on transport”.

Additionally, VELO requires no device maintenance. No batteries to charge, no coils to replace, no e‑liquid to refill, no cleaning. You simply open the can, take a pouch, and use it. This simplicity is a major draw for users who find vape devices cumbersome or unreliable.

A VapeSuperstore review summarises it well: “VELO nicotine pouches are tobacco-free, discreet, and easy to use, making them a practical alternative to smoking or vaping in situations where discretion matters”.

2026 Market Trends: VELO’s Rapid Growth

The nicotine pouch market — led by brands like VELO and ZYN — is experiencing explosive growth. According to Global Market Insights, the nicotine pouches market was valued at USD 8.6 billion in 2025 and is expected to grow to USD 9.9 billion in 2026, reaching USD 56.7 billion by 2035 at a CAGR of 19.4%.

While Philip Morris’ ZYN still leads with approximately 26% market share, British American Tobacco’s VELO captured two‑thirds of category growth in late 2025, intensifying competition. BAT reported a 2.3% rise in annual profit to £11.28 billion ($15.36 billion), driven by VELO gaining market share from both Altria’s On! and Philip Morris’ ZYN in the US market.

VELO now holds the second‑highest market share in the US, trailing only ZYN. The brand’s success is partly attributed to offering higher nicotine strengths (up to 17mg) and introductory offers as it grows the brand.

In the UK, VELO has become the No. 1 Nicotine Pouch, widely available in major supermarkets including Sainsbury’s, Tesco, The Co‑op, Asda, and Morrisons.

The shift from vaping to pouches is not just anecdotal. With the UK disposable vape ban taking effect in June 2025, many adult vapers have been seeking alternatives. Nicotine pouches like VELO have become a natural choice — offering a smoke‑free, vapour‑free experience without the hassle of rechargeable devices.

In Japan, BAT launched two new VELO flavours in February 2026: Smooth Peppermint Medium (4mg, beginner‑friendly) and Breezy Mango Intense (6mg), each containing 15 pouches per can. This reflects the brand’s continued global expansion and product innovation.

Regulatory Landscape: FDA and Nicotine Pouches in 2026

As of April 2026, the regulatory status of nicotine pouches in the US remains complex. The FDA launched a fast‑track review program for nicotine pouch products, but approvals have stalled as agency scientists weigh concerns about youth uptake and risks to non‑users.

According to an April 1, 2026, Reuters exclusive, “Popular nicotine pouch products have yet to be cleared for sale in the United States despite a fast‑track Food and Drug Administration scheme, as agency scientists hesitate to authorise them due to potential risks to new users, including children”.

The FDA’s concerns relate to “risks to youth or other non‑users, such as driving addiction in adults who do not already smoke”. The agency says “nicotine products are highly addictive and are not risk‑free even for adults, while nicotine can harm developing brains. Pouches, however, are generally less harmful than cigarettes, and when smokers switch completely scientific data indicates they can lower health risks”.

BAT has stated that its VELO applications “warrant the agency’s authorisation given robust scientific support, and that it continues to engage constructively with the agency”.

Six pouches under Altria’s on! PLUS label were granted licences in December 2025, but applications related to four other pouch brands — including newer versions of VELO and ZYN — are still pending.

It is worth noting that the FDA has already authorised 20 ZYN products (January 2025), demonstrating that nicotine pouches can meet FDA standards. VELO’s applications remain under review, but the scientific evidence supporting its reduced‑risk profile is substantial.

Which One Should You Choose?

The choice between VELO and vaping depends on your priorities.

Choose VELO if you:

• Want to avoid any lung exposure — no inhalation, no aerosol

• Need maximum discretion — invisible, odourless, usable anywhere

• Don’t want to deal with devices — no charging, no refilling, no maintenance

• Prefer a longer, more sustained nicotine experience (30 minutes per pouch)

• Want to avoid visible vapour clouds

• Travel frequently or use nicotine in restricted environments

Choose vaping if you:

• Prefer a faster, more cigarette‑like nicotine hit

• Enjoy the sensory experience of inhaling vapour

• Don’t mind device maintenance and public visibility

• Already have vape devices and prefer not to switch

As the Medscape analysis notes, “With pouches, the nicotine is absorbed through the oral mucosa into the bloodstream, much like medicinal nicotine replacement therapy (NRT)”. For many former smokers, this slower, more controlled absorption is actually preferable — avoiding the sharp spikes and crashes associated with both cigarettes and vaping.

Frequently Asked Questions

Is VELO safer than vaping?

Based on current evidence, VELO is likely less harmful than vaping for adult smokers who switch completely. This is primarily because VELO involves no lung exposure whatsoever, eliminating the respiratory risks associated with inhaling aerosol. However, both products are significantly less harmful than continued cigarette smoking, and neither is risk‑free.

Can I use VELO to quit vaping?

Many adult vapers have successfully switched to VELO, especially following the UK disposable vape ban in June 2025. VELO provides a smoke‑free, vapour‑free nicotine experience without the hassle of device maintenance. However, VELO is not FDA‑approved as a cessation aid, and it still contains addictive nicotine.

Does VELO produce vapour?

No. VELO produces no vapour, no smoke, and no aerosol. It is completely vapour‑free.

Can I use VELO on a plane?

Yes. Because VELO produces no vapour, no smoke, and no odour, it can be used discreetly on flights and in other environments where smoking and vaping are prohibited.

Do I need a device for VELO?

No. VELO requires no device — just the pouch itself. This makes it one of the most convenient nicotine products available.

Is VELO addictive?

Yes. VELO contains nicotine, which is an addictive chemical. However, clinical studies have shown that VELO has a lower abuse liability profile than cigarettes and is similar to NRT gum, suggesting a reduced potential for abuse compared to cigarettes.

The Bottom Line

VELO is not a form of vaping — it is a fundamentally different product. Vaping involves inhaling aerosol into the lungs; VELO involves absorbing nicotine through the gums. Vaping requires a device, batteries, and ongoing maintenance; VELO requires nothing but the pouch itself. Vaping produces visible vapour and noticeable odour; VELO is completely invisible and odourless.

As the VELO brand itself explains: “They deliver nicotine through the gums — no heat, no smoke*, no vapour”.

For adult smokers looking for a smoke‑free alternative, both products offer advantages over continued cigarette use. But for those who prioritise discretion, simplicity, and zero lung exposure, VELO has clear advantages over vaping.

The 2026 market trends reflect this shift. As the nicotine pouch market grows toward USD 9.9 billion in 2026 and beyond, brands like VELO are capturing an increasing share — not from cigarettes alone, but from vapers seeking a cleaner, more discreet, device‑free alternative.

Whether VELO is right for you depends on your personal preferences, nicotine needs, and lifestyle. But one thing is clear: VELO is not vaping. It is something entirely different — and for millions of adult users, that difference is exactly what they have been looking for.

Shop Authentic VELO Nicotine Pouches at SmokerBar

At SmokerBar, we carry the full range of authentic VELO nicotine pouches — from 4mg Mellow to 17mg Intense — in all your favourite flavours: Freezing Peppermint, Cherry Ice, Mango Ice, Strawberry Ice, Bright Spearmint, Tropical Mango, Ruby Berry, and more. All products are sourced directly from authorised distributors, stored fresh, and shipped discreetly with age verification (18+ or 21+ depending on local laws).

Browse our VELO collection today — and experience the vapour‑free alternative.

Disclaimer: This product contains nicotine. Nicotine is an addictive chemical. For adult nicotine users aged 18+ only. This article is for informational purposes and does not constitute medical advice. If you do not use nicotine, do not start. Keep out of reach of children and pets.